Monitoring of serotypes and their clonal associations is critical as
The effects of the pneumococcal seven-valent conjugate vaccine (PCV7) upon the genetic structure of the pneumococcal population and on serotype-genotype associations are still unknown, since PCV7 was only licensed in 2000. Although PCV7 has been very effective in decreasing the prevalence of PCV7 and PCV7-related (PCV7R) serotypes among pediatric isolates, there are reports of serotype replacement, representing increases of serotypes not targeted by PCV7 (16, 19, 23, 31, 33) . Recently, in a country that does not use PCV7, multiresistant strains of nonvaccine serotypes have been characterized and shown to be probable capsular switch variants of highly successful clones of PCV7 serotypes (29) . Such findings are important, since variants not targeted by vaccines have the potential to become highly successful pathogens within the pediatric population. Genetic characterization of replacement strains and monitoring of their prevalence over time within specific geographic areas will determine the relative impacts of newly emerging strains, of strains arising by capsular switching, and of already established strains. With time, active surveillance may detect all three categories of replacement strains that may increase as a result of intense PCV7 pressure. These issues can be addressed only with accurate molecular surveillance over extended periods.
Previously, we used pulsed-field gel electrophoresis (PFGE) of chromosomal SmaI digests combined with multilocus sequence typing (MLST) to describe the clonal structure within the majority of serotypes commonly observed among isolates causing invasive disease immediately prior to the introduction of PCV7 (12) . That work provided the baseline information of PFGE profiles associated with MLST identifiers for future comparisons. The present study was undertaken with the objectives of continuing the active molecular surveillance of invasive pneumococcal isolates collected during each year of Active Bacterial Core surveillance (ABCs) (1) subsequent to PCV7 implementation and comparing these results to the baseline information obtained during previous years. Here we present the findings of the genotypic surveillance of selected pneumococcal isolates collected in the 2 years immediately following PCV7 introduction. Declines in the numbers of invasive pneumococcal disease cases due to the clonal types targeted by PCV7 serotypes compared to the numbers of cases in 1999 and increases in the numbers of invasive pneumococcal cases due to strains within clonal types not targeted by the vaccine are shown.
All instances of strong PFGE similarity between isolates of different serotypes were examined by MLST.
CCs. STs were divided into sets by using eBURST (11) , which is available at the MLST database (28) . eBURST sets have the requirement in which all STs must be a single-locus variant (SLV) of at least one other ST within the group and are illustrated by solid vertical lines in Fig. 1 . Founder STs were defined as described previously (11) as being the ST within the eBURST set that has the greatest number of single-locus variants (STs in color in Fig. 1 ). For this work clonal complexes (CCs) consisted of eBURST sets or eBURST sets plus related STs that shared five of seven allelic identities with at least one ST within the set (double locus variants [DLVs] ) and, additionally, that shared at least four allelic identities to the majority of the other STs included within the set.
Clonal sets. The 83 total clonal sets referred to in this report refer to each of the genetically nonoverlapping CCs and STs that we have documented from ABCs ( Fig. 1) . All CCs and individual STs that include 1 of the 26 currently recognized internationally disseminated clones of PMEN (27) are underlined throughout this report. For example, clonal complex 37 (CC37) includes ST37 from PMEN clone Tennessee 23F -4 and refers to the six-member clonal group shown in Fig. 1 plus the related STs 628, 629, and 42.
Assignment of clonal set designations by PFGE. All isolates of the same serotype that shared Ն80% genetic relatedness within unweighted pair group method with arithmetic means-generated PFGE clusters (restricted to a single serotype) that included at least one isolate of a known ST were assigned within a clonal set (ST or clonal complex). The validity of this strategy was demonstrated previously (12) . MLST was performed with all isolates of different serotypes that shared related PFGE profiles.
RESULTS
Invasive pneumococcal disease. Analysis of pneumococcal isolates that caused invasive disease revealed that, with the exception of serotype 19A, the incidence of disease due to PCV7 serogroups decreased markedly during 2002 compared to the incidence in 1999 overall and in both age groups (Table 1) . This was especially evident in 2002 for the pediatric (Ͻ5-year-old) age group, in which a nearly eightfold reduction in disease incidence due to serogroups contained in PCV7 (excluding serogroup 19A) was evident relative to the incidence in 1999 (P Ͻ 0.001). In contrast, the incidence of invasive disease in the pediatric population due to non-PCV7 serogroups (and serogroup 19A) increased 1.5-fold in 2002 relative to the incidence in 1999 (P Ͻ 0.001). Compared to the proportion of cases in 1999, the proportion of cases due to non-PCV7 serotypes 3, 7F, 15BCF, 19A, 22F, 33F, and 38 significantly increased in 2002 (P Յ 0.002; 25 were closely similar (SLVs or DLVs) to STs with the same serotype, as listed in the MLST database (28) . However, nine of these new STs (SLVs or DLVs) had serotype associations that were not described previously. Five of these nine new associations included STs associated with PCV7NR serotypes. The five serotype-ST associations 15BC-ST1259, 15BC-ST1267, 20-ST1261 (CC899), 10A-ST1263, and 12F-ST1376 (CC1292) potentially depict descendants of STs associated with PCV7 serotypes due to their relatedness with Closely related outliers within the same clonal set are connected to eBURST sets by dotted lines. Numbers in red indicate STs calculated as founders by using eBURST with the STs generated from this study and also calculated as founders by using all known STs (28 (2, 8, 12) , the various divergent ddl alleles encountered during this work were always associated with penicillin-nonsusceptible isolates.
Serotype-genotype associations of invasive pneumococcal isolates compared to those in the pneumococcal MLST database. In general, STs were restricted to the same serotype and the results between our data set ( Fig. 1 ) and the pneumococcal MLST database (28) were concordant. All instances of multiple serotype associations with single STs found in our study are shown in Fig. 1 . For each ST, any differing serotype association patterns listed at the MLST database as of December 2004 are in parentheses (Fig. 1) .
Clonal sets. Eighty-three nonoverlapping clonal sets were documented from the 1999 to 2002 surveillance for invasive pneumococci (Fig. 1) . Six of the founder STs for clonal complexes shown in Fig. 1 were calculated independently with eBURST by the use of our study-limited data set of 177 STs and were also determined to be founders, based on the data set containing all known STs in the database at mlst.net (1,510 STs as of 20 December 2004; these founder STs are indicated in red in Fig. 1 ). Twenty-three additional STs that were detected during our surveillance and that were predicted founders, based on the total ST data in the MLST database, are indicated in green in Fig. 1 . Seven additional founders were predicted solely on the basis of the analysis of the STs found during this study (indicated in blue). The total of 36 "founder" STs generally represent STs that were most commonly found within the indicated clonal sets (Fig. 1) , consistent with these particular strains being the originators of the clonal sets (11) .
The relationships of the 83 clonal sets that were compiled by using study STs alone (the single STs that are listed but that a The surveillance areas are the same as those listed in footnote a of Table 1 . b Projected number of cases in the group Ͻ5 years of age for the indicated surveillance areas since serotypes were not determined for 171 of the total (n ϭ 1,167) year 1999 isolates and were not determined for 41 of the the total (n ϭ 308) year 2002 isolates.
c Percentage of total isolates recovered from this age group in the indicated year.
d Comparison of proportions for serotypes which have Ն2% of total strains in at least 1 year by using the chi-square or the Fisher exact test.
are not highly related to others included in Fig. 1 are also considered clonal sets) are highly congruent with nonoverlapping eBURST groups and singlets (without DLVs within the study set) derived from all known STs (28) . The exceptions to this involve 11 clonal sets that include CC138, CC172, CC226, CC156, CC1269, CC425, CC146, ST18, CC460, CC1292, and CC392 (Fig. 1) In summary, with the exceptions listed above, the 83 clonal sets derived from our study isolates closely correlated to the 86 clonal groups derived by eBURST analysis of the entire pneumococcal MLST database (28) .
Genetic structures of individual serotypes. PCV7 and PCV7R serotypes displayed an overall increased degree of genetic complexity (48 CCs and 124 STs) relative to that of the PCV7NR serotypes (37 CCs and 52 STs) ( Fig. 1 ; see Table 4 ). This could be due in part to the fact that more PCV7 and PCV7R isolates than PCV7NR isolates (1,534 versus 1,012 total isolates) were analyzed from the 3 years. However, it is apparent that PCV7NR serotypes displayed a maximum of five clonal sets (within 15B/C), with types 1, 3, 7F, 10A, 11A, 12F, 15A, 15B/C, 22F, 33F, and 38 each primarily comprised of one distinct clonal set. In contrast PCV7 or PCV7R serotypes 6A, 6B, 14, 19A, 19F, and 23F each displayed 6 to 14 clonal types, with types 6A, 6B, 19F, and 23F each containing three major clonal sets that accounted for 5 to 35% of the isolates analyzed within their respective serotypes during each year (Fig. 2) . A higher number of distinct clonal sets was most often observed within serotypes with a high percentage of penicillin-nonsusceptible isolates (including serotypes 6A, 6B, 14, 19A, 19F, and 23F) (Fig. 2) . Two exceptions to this observation included serotype 9V, which primarily consisted of only two highly related clonal clusters or groups during all 3 years (CC156 and CC1269, which are included in a single eBURST cluster when all existing STs are considered), and serotype 35B, which consisted of a penicillin-nonsusceptible clonal group and a distinct penicillin-susceptible clone (CC377 and ST452, respectively) (2). PCV7 serotype 4 and PCV7 serogroup 18 (primarily serotype 18C) consisted entirely of penicillin-susceptible isolates.
Serotype associations within clonal sets. Sixty-three of the 83 clonal sets were represented solely by single serotypes. Forty-one clonal sets represented only PCV7 or PCV7R serotypes and were not inclusive of PCV7NR serotypes during the years of this study.
Although 22 of the 83 clonal sets shown in Fig. 1 were associated with multiple serotypes (25 of the clonal sets were associated with multiple serotypes, if the serotype distribution listed in the pneumococcal MLST database is also considered; see the serotypes in parentheses in Fig. 1 ), only 9 of these were associated in this study with both PCV7-PCV7R and PCV7NR serotypes. Ten clonal sets were associated with both PCV7R and PCV7NR serotypes if the serotype distribution listed in the pneumococcal MLST database is also taken into consideration (see ST230 in Fig. 1 ).
Of the nine clonal sets containing both PCV7-PCV7R and PCV7NR serotypes (CC62, CC63, CC156, CC199, CC899, CC662, CC460, CC1257, and CC1292), we observed only three instances in which a PCV7NR serotype strain shared a clonal complex where other members were associated only with PCV7 and PCV7R serotypes. One such instance was observed within CC156. Within CC156, which is comprised almost entirely of PCV7-related strains, we found a single ST162 Table 4 ). PMEN clones. Isolates highly related to 17 of the 26 currently recognized PMEN clones were detected within our sample set (Table 3) . From 1999 to 2002, large fractions of individual PCV7 or PCV7-related serotypes were comprised of isolates highly related to various PMEN clones primarily of the same serotypes (Tables 3 and 4 ; Fig. 2 ). Thirty-one percent of the isolates within the 1999 study set were highly related to individual PMEN clones listed in Table 3 , whereas 28.2% of the isolates in the 2001 study set were highly related to individual PMEN clones. With the exception of CC289 from serotype 5, the isolates represented by these clones contained a high percentage of penicillin-nonsusceptible isolates (Fig. 2) . Although the 2002 genotype surveillance focused primarily upon non-PCV7 serotypes, 26.5% of the isolates in this sample were within genetic sets representing PMEN clones. PCV7NR serotype 35B was comprised in large part of penicillin-nonsus- , and 2002, respectively. The NPIs analyzed depict the numbers of isolates from individuals 5 years of age or older that were subjected to PFGE. The PIs analyzed depict the numbers of isolates from individuals less than 5 years of age that were subjected to PFGE. The percentages depict the proportions of invasive pneumococcal isolates within these serotypes that were subjected to genetic analysis. Where the numbers corresponding to these percentages are in parentheses, they refer to the total numbers of ABCs isolates within that age and serotype. The letter P indicates that at least 15% of the indicated clonal set within the indicated serotype were penicillin nonsusceptible. Serotypes in parentheses are shown when the serotype distributions listed in the global database (28) differed in any way from what we observed. Underlines indicate STs directly shared by PMEN clones (27) or clonal complexes containing these STs found among PMEN clones. Up to 30% of the isolates within a given serotype had unique PFGE profiles and were not subjected to MLST (represented by gaps in the columns). Such isolates could possibly belong to any of the clonal sets included or could represent additional clonal sets. Table 4 ).
Associations of specific clonal types with patient age. In general, when specific serotypes were amply represented by both PIs and NPIs, there were few examples of preferential clonal associations with certain age groups. Within this survey, 22 clonal set-serotype associations were found only within NPIs (Table 4 , indicated in boldface). While the significance of these observations, if any, is as yet unknown, it is possible that these represent strains that are more commonly present among individuals 5 years of age or older. For example, CC1292 represented 9 isolates (18%) of the serotype 6A NPIs characterized from the 2001 and 2002 isolate sets, yet it was not found among 51 PIs that accounted for nearly all serotype 6A PIs from the same period. Similarly, CC1296 and ST1340 were not found in extensive surveys of both 1999 and 2001 serotype 19F PIs, yet they were found in a limited sampling of year 2002 NPIs. Certain genotypes were found only among NPIs, because the corresponding serotypes were not found among PIs (serotypes 13, 15A, 28F, and 37).
Resistance phenotypes. In general, resistance to antibiotics was uncommon within serotypes which were represented primarily by penicillin-susceptible isolates. Resistance to erythromycin was common within most penicillin-nonsusceptible genetic sets specific to PCV7 or PCV7R serotypes and is not described here in detail. Occasional instances of resistance to one or more of the antibiotics co-trimoxazole, tetracycline, and chloramphenicol occurred within most serotypes and are not generally described here. During 2001 and 2002 fluoroquinolone resistance was seen only within serotypes 3 (three isolates), 4 (three isolates), 6B (four isolates), 9N (one isolate), 14 (five isolates), 15A (one isolate), 15B (one isolate), 18C (three isolates), 19A (two isolates), 19F (four isolates), 20 (one isolate), 22F (one isolate), 23A (one isolate), and 35B (one isolate), with most assigned to clonal sets common to their serotype (26; this work). Penicillin nonsusceptibility at frequencies of 15% or higher within specific genetic sets is referred to in Fig. 2 with the letter P and includes serotypes 6A, 6B, 7B, 9A, 9N, 9V, 14, 16F, 19A, 19F, 23A, 23F, and 35B.
Comparison of PCV7NR serotypes pre-and postvaccination. We targeted all available PIs from PCV7NR serotypes and additionally included certain NPIs nonsusceptible to erythromycin, clindamycin, beta-lactam antibiotics, or fluoroquinolones. Below, the resultant data for each serotype from the 2001 and the 2002 data sets are combined and compared to the year 1999 data.
(i) Serotype 1. A majority of the serotype 1 isolates in the present study were grouped within ST227, similar to our findings in the prevaccination period (12) . ST227 included all PIs, including one that was intermediately penicillin resistant. Two minor STs (STs 217 and 1174) accounted for a total of five year 2001 NPIs. The data are in agreement with those from a recent report showing that ST227 is characteristic of a lineage (lineage A) of serotype 1 pneumococci that are apparently exclusive to Europe and North America (4). ST1174 shares only three loci with ST227; however, it shares six loci with one of the other STs within lineage A. ST217 is typical of lineage B serotype 1 pneumococci that are predominant within Africa and Israel (4) and is reported to represent a hypervirulent clonal complex (18) .
(ii) Serotype 3. As in the year 1999 surveillance, the majority of serotype 3 isolates (both PIs and NPIs) after vaccine introduction were within clonal set ST180. These included 13 antibiotic-resistant NPIs, including all 3 levofloxacin-resistant serotype 3 NPIs from 2001 and 2002 (26) and 10 erythromycinresistant isolates (including the single PI and 9 of 22 NPIs from the 2 years).
(iii) Serotype 5. The two serotype 5 isolates (one PI and one NPI, both of which were collected in 2001) had PFGE profiles highly similar to the profile from the single NPI described in the year 1999 surveillance, which was ST653. ST653 is a DLV of ST289, the tetracycline-resistant PMEN clone Colombia 5 -24 (27) . Only the year 2001 NPI was resistant to antibiotics (tetracycline and co-trimoxazole).
(iv) Serotype 7B. None of the isolates from 2001 to 2002 were serotype 7B, and so no comparison to the single penicillin-nonsusceptible ST664 PI recovered in 1999 could be made.
(v) Serotype 7C. The three serotype 7C isolates genotyped shared highly similar PFGE profiles. These included one PI and a penicillin-nonsusceptible, tetracycline-resistant NPI with the novel ST ST1207 (which has only three allelic identities with the closest matches).
( (viii) Serotype 10A. Due to the presence of STs 816 and 1208, which were shared among a PFGE cluster of highly related profiles, the majority of serotype 10A isolates (including all PIs) were assigned to CC460, which includes ST460, an ST commonly seen among serotype 6A isolates. Two of the a Clonal complexes in boldface were found only among isolates from individuals Ն5 years of age. Up to 30% of the isolates within a given serotype had unique PFGE profiles and were not subjected to MLST (represented by gaps in the columns in Fig. 2 (xii) Serotype 15A. There were no serotype 15A PIs in our surveillance. The 15 intermediately penicillin-resistant NPIs (which were also resistant to combinations of clindamycin, erythromycin, and tetracycline) tested from the years 2001 and 2002 were determined by PFGE and MLST to be identical or highly related to ST63 from the PMEN clone Sweden 15A -25 (27) . The single levofloxacin-resistant isolate from 2001 and 2002 (a year 2002 NPI) was ST817, which is unrelated to ST63 and which was initially reported from a serogroup 15 conjunctivitis isolate in Scotland (28) .
(xiii) Serotypes 15B and 15C. The incidence of ABCs PIs with serotypes 15B and 15C incrementally increased in 2001 and 2002 relative to the incidence in 1999 (Fig. 2, Table 2 ). Serotypes 15B and 15C interconvert (32) , which is consistent with the observation that ST199 was the most common ST found among U.S. invasive isolates of both serotypes during this surveillance ( Fig. 2; Fig. 1 and 2 (28) .
(xx) Serotype 31. The four serotype 31 NPIs genotyped from the 3 years shared highly similar PFGE profiles, and two of these NPIs were directly determined to have ST568, previously described from a serotype 31 cerebrospinal fluid isolate recovered in Scotland (28) . The 1999 and 2002 NPIs chosen for analysis showed elevated fluoroquinolone MICs (ciprofloxacin MICs, 4 to 8 g/ml; levofloxacin MICs, 2 g/ml).
(xxi) Serotype 33F. There were incremental increases in the numbers of pneumococcal serotype 33F PIs causing invasive disease in 2001 and 2002 compared to the numbers in 1999 (Table 2 ; Fig. 2 ). Erythromycin-resistant serotype 33F PIs increased with time, accounting for one year 1999 PI (14%), six year 2001 PIs (37.5%; four were genotyped), and eight year 2002 PIs (42%). All but two of these isolates (96%) tested from the 3 years, including all erythromycin-resistant isolates, were CC662, which is comprised of STs previously associated with type 33F invasive isolates. Two antibiotic-sensitive year 2001 isolates (one PI and one NPI) were found to be ST1012, previously reported from a year 1998 serotype 11A cerebrospinal fluid isolate recovered in Poland (28 Fig. 2; Table 2 ). All isolates examined from the 3 years (27 PIs and 1 NPI) were highly related on the basis of combined PFGE and MLST analysis. Four independent isolates were sequence typed as ST393. ST393 was previously associated with a type 38 carriage strain recovered during 1998 in the United Kingdom (28) .
Pre-and postvaccination genetic structures of PCV7R serotypes. (i) Serotype 6A. Serotype 6A displayed a total of 12 different clonal sets among the isolates examined from all 3 years, 4 of which (CC1296, CC460, CC473, and ST395) were evident among multiple isolates in the present study as well as among multiple isolates in 1999. Eight of the 12 clonal sets exhibited high levels of penicillin nonsusceptibility and resistance to other antibiotics. As in 1999, CC1296 (including ST376 of the PMEN clone North Carolina 6A -23 [14, 27] ) was common in 2001 and 2002.
The six distinct clonal sets CC490, CC138, ST690, ST1091, ST1175, and CC1292 accounted for 17 serotype 6A isolates from 2001 and 2002 and were not found among year 1999 isolates. Nine CC1292 NPIs (six penicillin-nonsusceptible isolates, including five isolates resistant to multiple antibiotics) that shared a high level of PFGE profile similarity, were recovered in 2001 and 2002 from four states. Two of these nine CC1292 NPIs were directly sequence typed as the newly discovered ST1292. ST1175, represented by a single isolate, was characterized by three new alleles and differed from its closest match at mlst.net by four loci. STs 138, 490, and 1091 have previously been seen among serotype 6A isolates from the United Kingdom, Finland, and Zambia, respectively (28) (note that ST138 is most commonly seen among serotype 6B isolates). ST690 has been associated with a serogroup 6 strain causing otitis media in the United States (28) .
(ii) Serotype 9A. As reported for the year 1999 surveillance (12), numerous (n ϭ 29) year 2001 isolates were mistakenly originally serotyped as 9A when they were actually serotype 9V, were resistant to multiple antibiotics, and were members of CC156. Only 3 of 32 multiresistant year 2001 NPIs initially tested as serotype 9A were still found to be serotype 9A after they were retested. These three serotype 9A isolates were also designated CC156, since one was directly typed as ST156 and all three had PFGE profiles nearly indistinguishable from those of multiple independent ST156 serotype 9V isolates. Of nine year 2002 NPIs (all penicillin nonsusceptible) initially tested as serotype 9A, six were subsequently found to be serotype 9V (and CC156), two were serotype 6A (one was CC473 and one was CC1292), and one was serotype 19A (CC199 (Fig. 1 , Table 2 ). It is also evident that the numbers of serotype 19A isolates recovered from both age groups have increased incrementally each year in the period from 2001 to 2004 (23) . Although about 70% of the 206 isolates analyzed in each of the 3 years shared CC199, 10 additional genetic sets were detected, 9 of which were comprised primarily of penicillin-nonsusceptible isolates with additional resistance determinants. Four of these nine multiply resistant clonal sets were comprised of isolates highly related to PMEN clones.
Multiresistant isolates highly related to PMEN clone Colombia 23F -26 (CC172) were apparent during all 3 years. Isolates related to Spain 23F -1 (CC81) were present in 1999 and 2002.
CC236, the clonal complex with Taiwan 19F -14 (ST236) as the predicted founder, was detected as a single multiply resistant ST271 PI within the 2001 isolate set. CC236 accounted for an additional ST (ST320) and five multiply resistant isolates (three PIs and two NPIs) among the year 2002 isolate set. Three of these isolates had very high levels of resistance to beta-lactam antibiotics (MICs of 8 g/ml for both penicillin and amoxicillin). It will be interesting to determine whether these multiresistant isolates carry both ermB and mefA determinants, as do other strains closely related to Taiwan 19F -14 that were recently characterized in a global study of community-acquired respiratory tract infections (10) .
CC1296, which contains ST376 from North Carolina 6A -23, was found only among the year 2002 isolates, accounted for nine isolates (five NPIs and four PIs) that were resistant to penicillin and cefotaxime and that were also resistant to erythromycin and co-trimoxazole. ST376 and ST1339 (a DLV of ST376) represented this nine-isolate cluster.
(v) Serotype 23A. Both serotype 23A PIs recovered from 1999 were penicillin nonsusceptible and were found to be ST338 (CC172), which is the genotype of PMEN -4] and which is associated with serotype 23A) were found in 2001 and 2002. Two of these three CC37 isolates were antibiotic resistant (one was resistant to clindamycin, erythromycin, co-trimoxazole, and tetracycline, while the other was resistant to levofloxacin). The levofloxacin-resistant isolate was ST629 and was originally found from an antibiotic-sensitive serotype 23F pediatric invasive isolate (11) .
Genetic structures of PCV7 serotypes. We targeted all available PIs from the 1999 ABCs (12) and the 2001 ABCs. Additionally, we added some NPIs for some serotypes, often targeting antibiotic-resistant isolates. Although PCV7 serotypes were not initially targeted from the 2002 data set, a small number of PCV7 serotype isolates that were originally mistakenly identified as non-PCV7 serotypes were included from the 2002 ABCs. Fluoroquinolone-resistant isolates were included from the 2002 ABCs.
(i) Serotype 4. As in 1999, CC899 was the major genetic cluster, accounting for 68% of serotype 4 isolates in 2001 ( Fig.  2 ; Table 2 ). It also included all four levofloxacin-resistant CC899 isolates (all NPIs) from the 2001 and 2002 ABCs (two of these were genotyped previously [26] ). ST205 accounted for 17 (24.6%) of the year 2001 serotype 4 isolates and 11.3% of the year 1999 serotype 4 isolates that were genotyped (Fig. 2) .
(ii) Serotype 6B. The four most frequently occurring clonal sets were the same between the 1999 and 2001 isolate sets (CC138, CC146, ST90 [Spain 6B -2] , and CC384 [Maryland 6B -17]), and three of these represented primarily multiresistant isolates (CC146, ST90, and CC384). Maryland 6B -17 was the most recently characterized of these multiresistant clones and was originally discovered among invasive isolates recovered in the United States in 1997 (14) . The five year 2001 and 2002 serotype 6B levofloxacin-resistant isolates were represented by ST138 (one NPI), CC146 (two NPIs) (26), ST690 (one NPI) (26) , and ST90 (one NPI).
The remaining clonal set from year 2001 to 2002, CC490, was comprised of penicillin-nonsusceptible isolates with nearly identical PFGE profiles associated with the DLVs ST1177 and ST1209.
(iii) Serotype 9V. Serotype 9V, unlike other PCV7 serotypes comprised of a large percentage of penicillin-nonsusceptible isolates, appeared to have a relatively simple genetic structure during all 3 years. Although two different clonal sets are shown for the years 1999 and 2001 because each had a distinct clonal group and founder ST defined by eBURST analysis of the study STs (Fig. 1) , these STs all lie within the same complex when the stringency is relaxed to include each ST that shares five identical alleles with at least one other member ST. All STs of CC156 and CC1269 share at least four identical alleles with ST156. Additionally, all of the component STs of these two genetic sets are within the same large eBURST group (73 STs, with founder ST156) when eBURST is performed with all known STs.
The nine CC156 isolates shown for year 2002 were all multiply resistant and were originally erroneously typed as either serotype 9A (six NPIs) or serotype 9N (two PIs and one NPI).
(iv) Serotype 14. Little difference between the genetic structure of the year 1999 PIs (208 isolates; 63.5% of the total serotype 14 PIs) and that in the 2001 data set (125 isolates, including 94.8% of total serotype 14 PIs) was seen. During both years, CC13 and CC124 accounted for the majority of the penicillin-nonsusceptible and the penicillin-susceptible isolates, respectively, and together accounted for more than 80% of the serotype 14 isolates. Although ST9 is predicted to be a more likely founder of this clonal complex when eBURST is extended to all known STs, ST13 was the most commonly encountered ST within CC13 and was the predicted founder by the use of only STs from this study (Fig. 1) .
While most isolates grouped within CC13 and CG124 during 1999 and 2001, the rest of the serotype 14 isolates were comprised of penicillin-nonsusceptible isolates from eight minor clonal sets. Three of these clonal sets were found only among the year 2001 isolates, including CC63, CC156, and ST554. It is interesting that two of these clonal sets represent clonal groups that include PMEN clones of different serotypes, including (v) Serotype 18C(BF). Ten isolates of serotype 18B or 18F are also included among the three data sets since all were found to be of CC113 or ST496, which are both commonly found within serotype 18C. These data suggest the possibility that serotypes 18C, 18B, and 18F interconvert.
The clonal distributions were similar within the 1999 and 2001 data sets. The five levofloxacin-resistant serogroup 18 ABCs isolates from 2001 and 2002 represented both CC113 (26) and ST496. Among the 2002 isolates was a PI that was resistant to clindamycin, erythromycin, co-trimoxazole, and tetracycline. This PI had a PFGE profile highly similar to that of the previously typed ST666 isolate from the year 1999 isolate set. The two other year 2002 PIs examined were serotype 18F and were within the major CC, CC113.
(vi) Serotype 19F. Serotype 19F exhibited 14 distinct clonal sets (more than any other serotype), 7 of which were associated with penicillin-resistant isolates (Fig. 2) Four year 2002 multiresistant NPIs were tested due to erroneous original serotyping results indicating novel associations of high-level beta-lactam resistance (penicillin MICs, 8 g/ml or greater) with serotypes 23A and 23B. All four isolates were found to be serotype 23F; three of these were within CC81, and one was in ST242.
DISCUSSION
The introduction of PCV7 has resulted in a dramatic reduction in invasive pneumococcal infections caused by the serotypes targeted by the vaccine (33) . However, the long-term effectiveness of the vaccine is not clearly known, in part due to the unknown extent that replacement disease-an increase in the incidence of non-PCV7 serotype disease-will become a factor. It is possible that PCV7 could have profound effects upon the prevalence and strain composition of individual serotypes that it does not target. The marked increase in the incidence of invasive disease due to serogroups not included in PCV7 (and serotype 19A) in 2002 relative to that in 1999 (P Յ 0.001) provides ample rationale for continued monitoring of individual serotypes within this set (Table 1) . It follows that certain individual non-PCV7 serotypes (serotypes 3, 7F, 15B/C, 19A, 22F, 33F, and 38) individually accounted for significantly higher proportions of invasive cases among children Ͻ5 years of age in 2002 relative to the proportions in 2001 (Table 2 ). These data are consistent with those from a recent report of the increase in the number of invasive pediatric cases due to serogroups 15 and 33 in the post-PCV7 era (16) . The cumulative data indicate a need for continued monitoring of invasive pneumococci to detect changes in serotype-genotype associations and to determine the effects of the vaccine on the pneumococcal population genetic structure. The focus of this work has therefore been to provide continuing serotype-specific data on invasive strains and to compare those data to our pre-PCV7 data (12) .
Sharing of the same ST among two or more serotypes is presumably indicative of past horizontal transfer events of capsular type-specific loci. Our data suggest that such capsular switching is a rare event since during the 3 years of this molecular surveillance study and the analysis of over 2,100 isolates we have detected only 11 STs associated with multiple serotypes. This is consistent with the findings of a recent study which found no evidence of capsular switching among 333 carriage isolates recovered from 100 children, including all isolates of different serotypes recovered from the same child (20) . It could be argued that we did not identify more putative instances of capsular switching because only 285 of these isolates were actually submitted to MLST (data not shown). We contend that our strategy of strategic MLST of representative related clusters within serotypes and of isolates involved in all unusual PFGE associations between isolates of divergent serotypes actually allows the targeting of more unusual multilocus sequence type associations than a strategy that uniformly targets a more limited number of isolates for MLST. In only 1 of the 11 instances of a shared ST between isolates of different serotypes (STs 629  23F,23A , 81  23F,19F , 138  6A,6B , 156  9A,9V ,  199  19A,15BC,19F , 271  19F,19A , 460  6A,23F , 644  6B,19F , 376  6A,19A ,  90 6B,6A , 69 6A,6B ) was the ST (ST199) associated with both PCV7-PCV7R and PCV7NR serotypes. However, it is noteworthy that ST199 accounted for the majority of serotype 15B/C and 19A isolates during 1999, even before the introduction of PCV7 (12) . The remaining 10 STs were shared only between isolates of PCV7 or PCV7R serotypes. Our data and the global data reveal relatively few instances in which identical or highly related STs are associated with both PCV7-PCV7R and PCV7NR serotypes. These findings are in marked contrast to those presented in a recent report (15) describing 11 instances of STs shared among multiple serotypes from a sample set of only 252 isolates, in which four STs were shared among PCV7-PCV7R and PCV7NR serotypes and in which three STs accounted for three to four different serotypes that included PCV7-PCV7R serotypes together with PCV7NR serotypes. In general, the data from our study indicate an extensive history of capsular switching between penicillin-nonsusceptible strains restricted to the PCV7 and the PCV7R serotypes but few deduced instances of genetic exchange involving strain pairs that represent both a PCV7-PCV7R serotype and a PCV7NR serotype. CC13, CC37, CC81, CC156, CC172, CC199, CC236, CC268, CC1269, and CC1296 are examples of clonal complexes documented here and elsewhere that are primarily associated with antibiotic-resistant strains and multiple PCV7 and PCV7R serotypes.
Of interest was the single example in which a single PCV7NR serotype (serotype 15B) PI had an ST (ST162 within CC156) that was previously reported primarily among strains with PCV7 serotypes (28) . Within CC156, we found an ST162 serotype 15B isolate recovered from the blood of an infant. ST162 is primarily associated with penicillin-sensitive and intermediately penicillin-resistant strains with PCV7 serotypes 19F, 9V, and 14 (28) . The recent observation of mul-tiply resistant serotype 11A isolate derivatives of the predicted founder strain Spain 9V -3 (ST156) within CC156 also supports the need for the continued monitoring of the clonal composition of serogroup 15 (29) . Although such occurrences appear to be rare at present, the constant usage of PCV7 may aid the expansion of such serotype switch variants with implications for the long-term effectiveness of the current vaccine.
The clonal structures of most serotypes characterized appeared to be stable by comparison to the prevaccine clonal structure data. Only 9 of the 83 clonal sets included both PCV7-PCV7R and PCV7NR serotypes, with only 3 of these clonal sets (CC156, CC1292, and CC899) in the post-PCV7 era showing new associations not previously seen in the pre-PCV7 period. Furthermore, three clonal sets which consisted primarily of PCV7NR serotypes prior to the introduction of PCV7 showed an association with PCV7-PCV7R serotypes only after PCV7 introduction (CC62 and CC63) or single isolates prior to PCV7 introduction (CC662). The other examples of such associations with both PCV7-PCV7R and PCV7NR serotypes include CC199, CC460, CC1257, and CC199. It is likely that CC460 was common within both serotype 6A and serotype 10A isolates before and after PCV7 introduction (Fig. 2) Of the nine clonal sets inclusive of both PCV7-PCV7R and PCV7NR serotypes, CC199 is currently the most important. Before and after the introduction of PCV7, CC199 accounted for the majority of both serotype19A and 15B/C isolates (Fig. 2) . Recent ABCs data indicate that the rate of invasive pneumococcal disease associated with serotype 19A is on the increase (23) . Also, other reports have indicated that serogroup 15 is an important component of serotype replacement occurring in vaccinated children (13) . Serogroup 15 and serotype 19A showed the most pronounced increases in incidence among invasive pediatric isolates in 2002 relative to the incidence in 1999 (Table 2) ; and these increases were associated with a corresponding increase in the incidence of CC199, which constituted 70 to 92% of both the serogroup 15 and the serotype 19A isolate sets in 2001 and 2002 (Fig. 2) . This trend has continued among the more recent year 2004 isolates analyzed (23) .
Since ST199 was the most common ST from both serotype 15B/C and serotype 19A isolates recovered from 1999 to 2002, presumably serotype 15B/C and 19A CC199 strains have a recent common ancestry. In contrast to serotype 15B/C isolates, which are penicillin susceptible, the majority of serotype 19A isolates are penicillin nonsusceptible, indicating that the serotype 19A derivative of ST199 might have originated following the transformation of a type 15B/C ST199 strain with serotype 19A-specific cps locus genes. It appears that PCV7 does not protect against the PCV7-related serotype 19A, which is consistent with the findings in a recent report in which a nine-valent conjugate vaccine protected against carriage by vaccine types and vaccine-related serotype 6A, with a concomitant increase in the rate of carriage of nonvaccine types (6 Table 4 ).
Among the PCV7NR serotypes, two additional clonal types have accounted for a larger proportion of pneumococcal isolates from invasive pediatric disease cases within the ABCs following PCV7 implementation. CC62 (which a showed a more than twofold increase in both years, with 14 to 20 serotype 33F isolates, respectively), and ST393 (which a showed a more than threefold increases incidence in 2002 relative to that in 1999, with 17 serotype 38 isolates) were observed to be the predominant clonal complexes within their respective serotypes even before PCV7 implementation ( Fig. 2; Table 4 ). These data correspond to the overall increase in the incidence of disease caused by serotypes 33F and 38 in 2002 relative to the incidence in 1999 (Table 3) . Extended surveillance will monitor the potential for these two clones to become common invasive pathogens in children.
Although the genetic structure of most serotypes remained relatively stable, the composition among some serotypes (e.g., serotypes 6A, 15B/C, and 19A) appeared to be altered to some degree through the occurrence of additional clonal sets when pre-and postvaccination data were compared (Fig. 2) . Although clonal sets were assigned for only 72 to 77% of the serotype 6A and 19A isolates from 1999 (Fig. 2) , we were unable to find matches between unassigned PFGE profiles from year 1999 isolates with PFGE profiles from the 2001 and 2002 data set. Therefore, it is unlikely that new clonal groups within these serotypes that were identified during 2001 and 2002 accounted for a major portion of unassigned year 1999 isolates. ST1292, one of the clonal sets not found within the 1999 serotype 6A isolates, shared only four allelic identities with its closest match at mlst.net at the time of its discovery within the 2001 isolate set. This ST is an SLV of ST1379 subsequently reported from a serotype 6A blood isolate recovered in Sweden in 2000 (28) . It is interesting that within this nine-isolate CC1292 set, a full range of penicillin resistance phenotypes is evident (sensitive, intermediately resistant, and fully resistant), indicating that this strain might be rapidly acquiring resistance.
Although this study has documented the maintenance of established serotype-clonal group associations and has documented new associations in the post-PCV7 era, it has limita- tions. The findings here are limited to strains obtained immediately after the introduction of PCV7. Pneumococcal populations evolve gradually, warranting long-term surveillance. Also, the study does not account for all pneumococcal isolates collected in the ABCs database, although the majority of the pediatric isolates from each year are accounted for (this is true even for 2002, where PCV7 serotypes were largely omitted). Nonetheless, the data do serve as a continuing reference point for future molecular studies that can be used to assess the impact of the vaccine upon the spectrum of invasive isolates collected from children in the United States. Additionally, targeted analysis of specific isolates from older individuals allows assessment of the clonal types associated with important antibiotic resistance. Genotyping of surveillance isolates led to a fairly extensive list of corrections of the phenotypic data, primarily due to the retesting of isolates with unusual serotype or resistance associations with STs. A modest degree of serotyping error has been found within other reference laboratories (17) , emphasizing that additional levels of quality control are desirable. We are currently targeting all isolates with serotypes associated with unusual antibiotic resistances or genotypes for the detection of potential phenotyping errors. The pneumococcal MLST database has proved very valuable for screening of serotype associations in this regard.
Recent studies have indicated that it is possible that pneumococcal serotypes, rather than specific clonal features, are the primary predictors of pneumococcal virulence (3, 5) . These studies have relied upon the relative number of isolates of specific clones and serotypes isolated from invasive infections relative to their occurrence during carriage. A contrasting report of a study that used a similar strategy indicated that specific clonal features other than the serotype could be important predictors of virulence (30) . It is possible that this general approach is misleading, since in many geographic locations a specific serotype might be limited to very little clonal variation. It is also possible that insufficient numbers of isolates within specific clonal types were recovered from either invasive infections or carriers, making comparisons difficult. Other potentially confounding aspects include the potential to not detect cocolonizing carriage strains and not detect carriage strains present in the upper respiratory tract in small numbers. One recent report (22) of a study that used a mouse model clearly showed profound differences in the invasiveness of two strains of various backgrounds that shared the same serotype and showed the similar invasiveness of two different serotypes that shared an otherwise identical genotype. It is hoped that further investigations will shed light on this issue. Continued meaningful integration of genetic identifiers, phenotypic data, disease manifestations, and demographic information will help to provide a better understanding of the epidemiology of this important pathogen.
